Table 3.
General characteristics of the study population after the exclusion of ten residual outliers (n = 98).
| Age | 72.7 ± 5.9 |
| Gender (males/females) | 53/45 |
| BMI (kg/m2) | 27.6 ± 4.0 |
| Total cholesterol (mg/L) | 197.5 ± 47.6 |
| HDL-C (mg/dL) | 47.8 ± 12.1 |
| LDL-C (mg/dL) | 119.1 ± 44.9 |
| Triglyceride (mg/dL) | 155.2 ± 70.2 |
| SBP (mmHg) | 139.5 ± 15.1 |
| DBP (mmHg) | 78.6 ± 7.4 |
| GSM | 30.9 ± 11.8 |
| NASCET (%) | 44.3 ± 20.9 |
| Hypertension, n (%) | 81 (82.7%) |
| Hypercholesterolemia, n (%) | 70 (71.4%) |
| Diabetes mellitus, n (%) | 19 (19.4%) |
| Smoking, n (%) | 11 (11.2%) |
| Creatinine (mg/dL) | 1.0 ± 0.2 |
| eGFR (mL/min/1.73 m2) | 72.1 ± 16.6 |
| SUA (mg/dL) | 6.0 ± 1.7 |
| SUA/SCr ratio | 6.2 ± 2.2 |
BMI: body mass index; HDL: high-density lipoprotein cholesterol; LDL: low-density lipoprotein cholesterol; SBP: systolic blood pressure; DBP: diastolic blood pressure; GSM: grayscale median; NASCET: North American Symptomatic Carotid Endarterectomy Trial; eGFR: estimated glomerular filtration rate; SUA: serum uric acid; SCr: serum creatinine.